Data / Form D filings / LyGenesis Inc.
LyGenesis Inc.: Form D filings
LyGenesis Inc., a biotechnology company in Pittsburgh, PA, filed 5 Form D notices with the SEC between 2018 and 2024. The latest, on October 11, 2024, reports $17.8 million sold of a $20 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1710 Murray Ave, Suite 200, Pittsburgh, PA, 15217
- Phone
- (412) 449-9983
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1739872
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | Amendment | $20,000,000 | $17,764,699 | $2,235,301 | 17 | Oct 5, 2023 | sec.gov |
| Oct 12, 2023 | New notice | $20,000,000 | $8,731,261 | $11,268,739 | 11 | Oct 5, 2023 | sec.gov |
| Dec 23, 2020 | New notice | $20,546,000 | $1,850,000 | $18,696,000 | 7 | Dec 14, 2020 | sec.gov |
| Oct 22, 2019 | New notice | $4,000,000 | $4,000,000 | 2 | Oct 18, 2019 | sec.gov | |
| May 18, 2018 | New notice | $3,210,527 | $2,210,527 | $1,000,000 | 2 | May 9, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Mellon | Director | |
| Steve Felstead | Director | |
| Eric Lagasse | Executive Officer, Director | |
| Justin Briggs | Director | |
| Michael Hufford | Executive Officer, Director, Promoter |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Oct 7, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LyGenesis Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.